| 摘要 |
This invention concerns the use of a therapeutically active agent for the manufacture of a pharmaceutical preparation useful in a method for prevention or treatment of ischemia reperfusion injury or multi-organ failure in an individual. According to the invention, said agent is plain interferon beta and said agent is intended for use without simultaneous administration of one or more agent affecting the adenosine level in individual. |
